Jianyong Xu

10PUBLICATIONS
6CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2025
CD317 stabilizes TNFR1 and confers the anti-inflammatory functions of MSCs via NF-κB/TSG6 pathway.

Si Chen, Lan Yao, Xin Wen

|Feb 03, 2025
Enhanced myofibroblast differentiation of eMSCs in intrauterine adhesions.

Jun Song, Meiqi Li, Yuan Tao

|May 15, 2024
Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.

Si Chen, Bowei Liang, Jianyong Xu

|Mar 28, 2024
Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3.

Shaoquan Shi, Si Chen, Bowei Liang

|Sep 24, 2022
TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities.

Lingyun Li, Lei Yang, Xian Chen

Pageof 2